Earnings Per Share

3 Months Ended

Mar. 31, 2022

As more fully discussed in the share-based compensation footnote of our notes to the consolidated financial statements in our 2021 Annual Report on Form 10-K, we maintain various long-term incentive plans, which provide for the granting of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance awards, dividend equivalents and other share-based awards. Certain outstanding options are not included in the diluted earnings per share calculation because their inclusion would have been anti-dilutive.

The following table summarizes anti-dilutive shares outstanding:


	Three Months Ended March 31,
	2022	2021
Anti-dilutive shares outstanding	1,341	—